| （単位：千ドル） | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | - | 16,146 | - | - | - |
| 売上原価 | - | - | - | - | - | - | 475 | - | - | - |
| 研究開発費 | 7,849 | 20,071 | 17,170 | 19,034 | 11,901 | 14,687 | 13,029 | 13,953 | 17,741 | 17,044 |
| 営業費用 | 11,621 | 31,389 | 25,726 | 28,393 | 20,954 | 25,354 | - | - | - | - |
| 営業利益 | -11,621 | -31,389 | -25,726 | -28,393 | -20,954 | -25,354 | -5,605 | -20,032 | -23,754 | -22,914 |
| 営業利益率 (%) | - | - | - | - | - | - | - | - | - | |
| 純利益 | -14,175 | -31,380 | -25,562 | -27,674 | -19,243 | -23,049 | -3,300 | -17,301 | -21,203 | -21,200 |
| 純利益率（％） | - | - | - | - | - | - | - | - | - | |
| 一株あたり利益 | - | - | -0.79 | -0.85 | -0.54 | -0.56 | -0.06 | -0.29 | -0.35 | -0.35 |
| 希薄化後一株あたり利益 | - | - | -0.79 | -0.85 | -0.54 | -0.56 | -0.06 | -0.29 | -0.35 | -0.35 |
| EBITDA | - | - | - | - | - | - | - | - | - |